Bioxcel Therapeutics Inc (BTAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Operating Expenses | 3,244 | 4,286 | 2,557 | 917 | 565 |
| Operating Income | -3,244 | -4,286 | -2,557 | -917 | -565 |
| Other Income | 218 | 4 | 8 | 0 | 0 |
| Pre-tax Income | -3,026 | -4,282 | -2,549 | -917 | -565 |
| Net Income Continuous | -3,026 | -4,282 | -2,549 | -917 | -565 |
| Net Income | $-3,026 | $-4,282 | $-2,549 | $-917 | $-565 |
| EPS Basic Total Ops | -3.04 | -5.92 | -4.00 | -1.60 | -0.96 |
| EPS Basic Continuous Ops | -3.09 | -5.98 | -4.11 | -1.55 | -0.95 |
| EPS Diluted Total Ops | -3.04 | -5.92 | -4.00 | -1.60 | -0.96 |
| EPS Diluted Continuous Ops | -3.09 | -5.98 | -4.11 | -1.55 | -0.95 |
| EBITDA(a) | $-3,244 | $-4,286 | $-2,557 | $-917 | $-565 |